Utility of Laboratory Test Result Monitoring in Patients Taking Oral Terbinafine or Griseofulvin for Dermatophyte Infections | Zendy

Deirdre Stolmeier | Zendy; Hannah B. Stratman | Zendy; Thomas J. McIntee | Zendy; Erik J. Stratman | Zendy

Open Access

Utility of Laboratory Test Result Monitoring in Patients Taking Oral Terbinafine or Griseofulvin for Dermatophyte Infections

Author(s) -

Deirdre Stolmeier,

Hannah B. Stratman,

Thomas J. McIntee,

Erik J. Stratman

Publication year - 2018

Publication title -

jama dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.128

H-Index - 166

eISSN - 2168-6084

pISSN - 2168-6068

DOI - 10.1001/jamadermatol.2018.3578

Subject(s) - griseofulvin , terbinafine , medicine , dermatophyte , itraconazole , neutropenia , dermatology , gastroenterology , chemotherapy , antifungal

Terbinafine hydrochloride and griseofulvin are effective oral treatments for dermatophyte infections but have been associated with hepatic and hematologic abnormalities. The prevalence of alanine aminotransferase elevations, aspartate aminotransferase elevations, anemia, lymphopenia, and neutropenia among adults and children taking terbinafine and griseofulvin is unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research